
Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway
Keywords: AFM; atomic force microscopy; CSCs; cancer stem cells; DMSO; dimethyl sulphoxide; ERK1/2; extracellular signal regulated kinase1/2; FAK; focal adhesion kinase; LCSCs; liver cancer stem cells; SFCs; sphere-forming cells; TSM; tumour sphere medium; Salinomy